Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
What Is Time-in-Range?

What Is Time-in-Range?

The Role of Pediatrician in Gaucher Disease

The Role of Pediatrician in Gaucher Disease

ASMD Phenotypes

ASMD Phenotypes

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

ADA 2021: Solimix Trial Summary

ADA 2021: Solimix Trial Summary

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Prophylactic Strategies for VTE in Gynecologic Cancer Patients

Prophylactic Strategies for VTE in Gynecologic Cancer Patients

BI hormonal CL systems

BI hormonal CL systems

Optimal use of LLT after ACS

Optimal use of LLT after ACS

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

The Lixilan-L Study

The Lixilan-L Study